New Research Chief Sees Foreign Cooperation on SSC

WASHINGTON—The Superconducting Supercollider will have international partners in its construction, promises the new acting director of the Office of Energy Research within the Department of Energy. On April 27 James Decker took over as head of the $1.8 billion research program when Alvin Trivelpiece became executive director of the American Association for the Advancement of Science. The 46-year-old Decker, who was hired by Trivelpiece in 1973 after working as a plasma physicist at AT&T B

Written byJeffrey Mervis
| 3 min read

Register for free to listen to this article
Listen with Speechify
0:00
3:00
Share

On April 27 James Decker took over as head of the $1.8 billion research program when Alvin Trivelpiece became executive director of the American Association for the Advancement of Science. The 46-year-old Decker, who was hired by Trivelpiece in 1973 after working as a plasma physicist at AT&T Bell Laboratories, has held a succession of departmental posts, most recently serving as the office's deputy director.

In an hour-long interview, Decker ticked off the range of issues facing the office, which operates nine multiprogram laboratories and 27 specialized facilities that employ more than 30,000 scientists and engineers. On the previous day he had waded through more than 400 questions fired at department officials by the dozens of states seeking help in preparing site proposals due August 3 for the $6 billion SSC project.

"I'm confident we will have international cooperation and participation on the SSC, first in the construction phase and ...

Interested in reading more?

Become a Member of

The Scientist Logo
Receive full access to digital editions of The Scientist, as well as TS Digest, feature stories, more than 35 years of archives, and much more!
Already a member? Login Here

Meet the Author

Published In

Share
Image of a man in a laboratory looking frustrated with his failed experiment.
February 2026

A Stubborn Gene, a Failed Experiment, and a New Path

When experiments refuse to cooperate, you try again and again. For Rafael Najmanovich, the setbacks ultimately pushed him in a new direction.

View this Issue
Human-Relevant In Vitro Models Enable Predictive Drug Discovery

Advancing Drug Discovery with Complex Human In Vitro Models

Stemcell Technologies
Redefining Immunology Through Advanced Technologies

Redefining Immunology Through Advanced Technologies

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Ensuring Regulatory Compliance in AAV Manufacturing with Analytical Ultracentrifugation

Beckman Coulter logo
Conceptual multicolored vector image of cancer research, depicting various biomedical approaches to cancer therapy

Maximizing Cancer Research Model Systems

bioxcell

Products

Sino Biological Logo

Sino Biological Pioneers Life Sciences Innovation with High-Quality Bioreagents on Inside Business Today with Bill and Guiliana Rancic

Sino Biological Logo

Sino Biological Expands Research Reagent Portfolio to Support Global Nipah Virus Vaccine and Diagnostic Development

Beckman Coulter

Beckman Coulter Life Sciences Partners with Automata to Accelerate AI-Ready Laboratory Automation

Refeyn logo

Refeyn named in the Sunday Times 100 Tech list of the UK’s fastest-growing technology companies